Although it was not clearly linked to any baseline characteristics associated with poor prognosis, MDM2 had borderline significance associated with negative regional lymph node involvement, which is generally a favorable prognostic factor.
← all excerpts
Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy.
1
—
—